Ikarian Capital, LLC - 30 Sep 2025 SCHEDULE 13G Report for Relmada Therapeutics, Inc. Common Stock, par value $0.001 par value per share (RLMD)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Relmada Therapeutics, Inc. Common Stock, par value $0.001 par value per share
Symbol: RLMD
Shares outstanding: 73,819,979 shares
Disclosed Ownership: 3,543,359 shares
Ownership: 4.8%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 18:28:02 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	4.8%	3,543,359	0	3,543,359	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	4.8%	3,543,359	0	3,543,359	/s/ Neil Shahrestani	Neil Shahrestani